Yuanbin Song. "TGM2 as a novel therapeutic target in venetoclax-resistant AML: Disrupting histone serotonylation-driven mitophagy with nanoparticle-delivered inhibitors." Blood, 2025. doi:10.1182/blood-2025-5058